tetano
Editor, Senior Moderator
Curr Cardiol Rep
. 2020 Jun 11;22(7):52.
doi: 10.1007/s11886-020-01327-9.
Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
Madan Raj Aryal[SUP] 1 [/SUP], Rohit Gosain[SUP] 2 [/SUP], Anthony Donato[SUP] 3 [/SUP], Ranjan Pathak[SUP] 4 [/SUP], Vijaya Raj Bhatt[SUP] 5 [/SUP], Anjan Katel[SUP] 6 [/SUP], Peter Kouides[SUP] 7 [/SUP]
Affiliations
Abstract
Purpose of review: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients.
Recent findings: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.
Keywords: COVID-19; Deep vein thrombosis; Extended prophylaxis; Pulmonary embolism; Thromboprophylaxis; Venous thromboembolism.
. 2020 Jun 11;22(7):52.
doi: 10.1007/s11886-020-01327-9.
Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
Madan Raj Aryal[SUP] 1 [/SUP], Rohit Gosain[SUP] 2 [/SUP], Anthony Donato[SUP] 3 [/SUP], Ranjan Pathak[SUP] 4 [/SUP], Vijaya Raj Bhatt[SUP] 5 [/SUP], Anjan Katel[SUP] 6 [/SUP], Peter Kouides[SUP] 7 [/SUP]
Affiliations
- PMID: 32529517
- DOI: 10.1007/s11886-020-01327-9
Abstract
Purpose of review: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients.
Recent findings: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.
Keywords: COVID-19; Deep vein thrombosis; Extended prophylaxis; Pulmonary embolism; Thromboprophylaxis; Venous thromboembolism.